Takashi Kanematsu Selected Research

Type C Phospholipases

12/2019	Phospholipase C-related catalytically inactive protein regulates lipopolysaccharide-induced hypothalamic inflammation-mediated anorexia in mice.
1/2018	Poor Motor-Function Recovery after Spinal Cord Injury in Anxiety-Model Mice with Phospholipase C-Related Catalytically Inactive Protein Type 1 Knockout.
2/2017	Phospholipase C-related catalytically inactive protein can regulate obesity, a state of peripheral inflammation.
1/2017	Suppression of cell migration by phospholipase C-related catalytically inactive protein-dependent modulation of PI3K signalling.
5/2014	Phospholipase C-related catalytically inactive protein (PRIP) controls KIF5B-mediated insulin secretion.
5/2013	Phospholipase C-related but catalytically inactive protein modulates pain behavior in a neuropathic pain model in mice.
3/2012	Dysfunction of extrasynaptic GABAergic transmission in phospholipase C-related, but catalytically inactive protein 1 knockout mice is associated with an epilepsy phenotype.
10/2011	Phenotypes of pain behavior in phospholipase C-related but catalytically inactive protein type 1 knockout mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Kanematsu Research Topics

Disease

40	Neoplasms (Cancer) 01/2021 - 01/2002
14	Hepatocellular Carcinoma (Hepatoma) 06/2013 - 05/2002
11	Neoplasm Metastasis (Metastasis) 08/2010 - 01/2002
10	Inflammation (Inflammations) 01/2022 - 11/2002
9	Carcinogenesis 07/2020 - 07/2002
9	Infections 04/2012 - 10/2002
9	Carcinoma (Carcinomatosis) 02/2011 - 07/2003
7	Colorectal Neoplasms (Colorectal Cancer) 11/2012 - 01/2002
7	Liver Failure 07/2012 - 01/2002
7	Pancreatic Fistula (Pancreatic Fistulas) 01/2011 - 01/2005
7	Acute Liver Failure (Fulminant Hepatic Failure) 10/2010 - 03/2002
6	Obesity 01/2022 - 02/2016
6	Pain (Aches) 11/2020 - 10/2011
6	Stomach Neoplasms (Stomach Cancer) 08/2015 - 01/2007
6	Pathologic Constriction (Stenosis) 11/2012 - 04/2003
5	Necrosis 10/2012 - 09/2002
4	Fibrosis (Cirrhosis) 01/2011 - 08/2008
4	Tics (Tic) 01/2010 - 05/2006
4	Fistula 10/2009 - 01/2005
3	Liver Neoplasms (Liver Cancer) 10/2019 - 11/2003
3	Neuralgia (Stump Neuralgia) 10/2014 - 05/2013
3	Starvation 01/2014 - 10/2006
3	Reperfusion Injury 10/2012 - 09/2003
3	Body Weight (Weight, Body) 11/2011 - 09/2007
3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2011 - 05/2008
3	Lacerations 04/2011 - 01/2003
3	Cholangitis 11/2010 - 02/2005
3	Peritonitis 11/2010 - 01/2007
3	Pancreatitis 01/2010 - 05/2008
3	Adenoma (Adenomas) 10/2009 - 07/2002
3	Thyroid Neoplasms (Thyroid Cancer) 01/2004 - 07/2002
2	Hypertrophy 01/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2011
2	Weight Loss (Weight Reduction) 01/2019 - 02/2017
2	Bone Neoplasms (Bone Cancer) 10/2014 - 01/2014
2	Cancer Pain 10/2014 - 01/2014
2	Hyperalgesia 10/2014 - 01/2014
2	Wounds and Injuries (Trauma) 08/2012 - 04/2011
2	T-Cell Leukemia (Leukemia, T Cell) 04/2012 - 05/2008
2	Aneurysm (Aneurysms) 11/2011 - 08/2008
2	Pancytopenia 11/2011 - 10/2010
2	Coinfection 10/2011 - 01/2010
2	Invasive Fungal Infections 05/2011 - 07/2010
2	Thrombosis (Thrombus) 01/2011 - 10/2010
2	Anastomotic Leak 01/2010 - 05/2006
2	Suppuration 01/2010 - 08/2006
2	Ductal Carcinoma 09/2008 - 10/2006
2	Papillary Carcinoma 04/2008 - 07/2002

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 09/2020 - 05/2002
8	Messenger RNA (mRNA)IBA 01/2022 - 05/2002
8	Type C PhospholipasesIBA 12/2019 - 10/2011
7	CytokinesIBA 01/2022 - 05/2004
5	Biological ProductsIBA 11/2012 - 03/2002
5	AntigensIBA 01/2008 - 01/2003
4	EnzymesIBA 01/2014 - 01/2002
4	SteroidsIBA 01/2012 - 05/2008
4	Contrast MediaIBA 07/2010 - 01/2005
3	Carcinoembryonic AntigenIBA 11/2012 - 12/2003
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2011 - 11/2002
3	InterferonsIBA 10/2011 - 08/2007
3	Thymidine PhosphorylaseIBA 03/2009 - 09/2003
2	Substance PIBA 01/2022 - 11/2020
2	Sucrose (Saccharose)IBA 01/2022 - 01/2021
2	LipidsIBA 01/2022 - 01/2021
2	LigandsIBA 01/2021 - 05/2002
2	Interleukin-6 (Interleukin 6)IBA 09/2020 - 07/2010
2	LipopolysaccharidesIBA 12/2019 - 10/2011
2	Phosphotransferases (Kinase)IBA 12/2019 - 10/2006
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 02/2017
2	LDL CholesterolIBA 01/2019 - 02/2017
2	CholesterolIBA 01/2019 - 02/2017
2	HDL CholesterolIBA 01/2019 - 02/2017
2	Morphine (MS Contin)FDA LinkGeneric 10/2014 - 01/2014
2	Opioid Analgesics (Opioids)IBA 10/2014 - 01/2014
2	Analgesics (Analgesic Drugs)IBA 10/2014 - 01/2014
2	Small Interfering RNA (siRNA)IBA 10/2014 - 01/2014
2	Insulin (Novolin)FDA Link 05/2014 - 11/2005
2	gadolinium ethoxybenzyl DTPA FDA Link 06/2013 - 04/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2012 - 03/2009
2	Cisplatin (Platino)FDA LinkGeneric 08/2012 - 05/2006
2	RNA (Ribonucleic Acid)IBA 07/2011 - 12/2003
2	Pharmaceutical PreparationsIBA 01/2010 - 01/2009
2	Etodolac (Lodine)FDA LinkGeneric 04/2008 - 02/2005

Therapy/Procedure

27	Liver Transplantation 09/2012 - 06/2002
18	Therapeutics 09/2020 - 06/2003
13	Transplantation 10/2014 - 01/2002
11	Hepatectomy 08/2012 - 03/2002
10	Pancreatectomy 11/2012 - 01/2005
8	Laparotomy 10/2012 - 01/2003
7	Pancreaticoduodenectomy 08/2012 - 05/2004
5	Operative Surgical Procedures 09/2010 - 01/2007
4	Pancreaticojejunostomy 01/2011 - 05/2006
3	Gastrectomy 08/2015 - 08/2008
3	Stents 01/2011 - 08/2006
2	Spinal Injections 10/2014 - 01/2014
2	Colectomy 03/2014 - 08/2006
2	Ligation 05/2013 - 11/2009
2	Conservative Treatment 11/2011 - 04/2006
2	Thrombectomy 07/2011 - 01/2011
2	Colostomy 03/2008 - 07/2004